Keeping up with COVID 19 (paper no. 2 )

 

Full paper can be found here :

https://onlinelibrary.wiley.com/doi/10.1111/all.14238

 

 

 

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

Jin-jin Zhang

Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China

Search for more papers by this author

Xiang Dong

Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China

Search for more papers by this author

Yi-yuan Cao

Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China

Search for more papers by this author

Ya-dong Yuan

Department of Respiratory and Critical Care Medicine, Second Hospital of Hebei Medical University, Shijiazhuang, China

Search for more papers by this author

Yi-bin Yang

Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China

Search for more papers by this author

You-qin Yan

Department of Infectious Disease, No. 7 Hospital of Wuhan, Wuhan, China

Search for more papers by this author

Cezmi A. Akdis

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland

Search for more papers by this author

First published: 19 February 2020
Citations: 6
Jin‐jin Zhang and Xiang Dong contributed equally to this work.
 
 

Abstract

Background

Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS‐CoV‐2.

Methods

Electronic medical records including demographics, clinical manifestation, comorbidities, laboratory data, and radiological materials of 140 hospitalized COVID‐19 patients, with confirmed result of SARS‐CoV‐2 viral infection, were extracted and analyzed.

Results

An approximately 1:1 ratio of male (50.7%) and female COVID‐19 patients was found, with an overall median age of 57.0 years. All patients were community‐acquired cases. Fever (91.7%), cough (75.0%), fatigue (75.0%), and gastrointestinal symptoms (39.6%) were the most common clinical manifestations, whereas hypertension (30.0%) and diabetes mellitus (12.1%) were the most common comorbidities. Drug hypersensitivity (11.4%) and urticaria (1.4%) were self‐reported by several patients. Asthma or other allergic diseases were not reported by any of the patients. Chronic obstructive pulmonary disease (COPD, 1.4%) patients and current smokers (1.4%) were rare. Bilateral ground‐glass or patchy opacity (89.6%) was the most common sign of radiological finding. Lymphopenia (75.4%) and eosinopenia (52.9%) were observed in most patients. Blood eosinophil counts correlate positively with lymphocyte counts in severe (r = .486, P < .001) and nonsevere (r = .469, P < .001) patients after hospital admission. Significantly higher levels of D‐dimer, C‐reactive protein, and procalcitonin were associated with severe patients compared to nonsevere patients (all P < .001).

Conclusion

Detailed clinical investigation of 140 hospitalized COVID‐19 cases suggests eosinopenia together with lymphopenia may be a potential indicator for diagnosis. Allergic diseases, asthma, and COPD are not risk factors for SARS‐CoV‐2 infection. Older age, high number of comorbidities, and more prominent laboratory abnormalities were associated with severe patients.

More to explorer

International Nursing Group for Immunodeficiencies Logo

INGID News November 2022

INGID 2022 ConferenceThank you very much to the 60 INGID members who travelled to Gothenburg for what has been described by many as one of our best ever conferences.  It

Read More »
International Nursing Group for Immunodeficiencies Logo

INGID Draft Programme Gothenburg 2022

We’re please to share our latest INGID DRAFT programme for ESID/INGID/IPOPI Conference in Gothenburg – October 12-15, 2022. Full event details of the ESID/INGID/IPOPI Conference can be viewed in our

Read More »
International Nursing Group for Immunodeficiencies Logo

INGID Election Process 2022

The election for a new board members and election committee members will start September 14, 2022. It will be an online voting process. The election process will end September 28, 2022.

Read More »
International Nursing Group for Immunodeficiencies Logo

Letter from the Board 2022

We are very happy to introduce you to the new website with an updated content in a new layout. The Director of Communications, Ruchi Saka, is working closely together with

Read More »
en English
X